StockData
Acurx Pharmaceuticals, Inc. logo

Acurx Pharmaceuticals, Inc. (ACXP) stock

ACXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.94−0.02 (-2.60%)

Close on Nov 16, 2026Market cap $4.93MP/E –Yield –

Acurx Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Acurx Pharmaceuticals's price to book ratio was 0.6× on Nov 11, 2026, against 1.9× a year earlier. Over the last 5 years it ranged from 0.6× to 19.6×, with a median of 4.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.6×−0.6
2025Dec 31, 20251.2×−2.6
2024Dec 31, 20243.8×−2.3
2023Dec 29, 20236.1×+1.4
2022Dec 30, 20224.6×+1.6
2021Dec 31, 20213.1×–

More Acurx Pharmaceuticals figures

See a number that looks wrong?